Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beverly Hills MD is a premium cosmeceutical brand founded in 2014 by plastic surgeons Dr. John Layke and Dr. Payman Danielpour. The company develops and markets advanced skincare products and dietary supplements aimed at addressing signs of aging, such as wrinkles, sagging skin, and dark spots. Their formulations often incorporate clinical-grade ingredients, including peptides, growth factors, and botanical extracts, designed to provide non-invasive alternatives to surgical procedures. Beverly Hills MD operates primarily through a direct-to-consumer model, leveraging digital marketing and educational content to reach its audience. The brand is part of the Golden Hippo portfolio of health and wellness companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beverly Hills MD.